Naringenin Nanoformulations for Neurodegenerative Diseases
Authors:
- 1 December 2024
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Biotechnology
- Vol. 25 (16) , 2108-2124
Abstract
: Glioblastoma (GBM) is a grade-IV astrocytoma, which is the most common and aggressive type of brain tumor, spreads rapidly and has a life-threatening catastrophic effect. GBM mostly occurs in adults with an average survival time of 15 to 18 months, and the overall mortality rate is 5%. Significant invasion and drug resistance activity cause the poor diagnosis of GBM. Naringenin (NRG) is a plant secondary metabolite byproduct of the flavanone subgroup. NRG can cross the blood-brain barrier and deliver drugs into the central nervous system when conjugated with appropriate nanocarriers and can overcome the challenges associated with gliomas through naringenin-loaded nanoformulations. Here, we discuss several nanocarriers employed as delivery systems, including polymeric nanoparticles, micelles, liposomes, solid lipid nanoparticles (SLNs), nanosuspensions, and nanoemulsions. These naringenin-loaded nanoformulations have been tested in various in vitro and in vivo models and administration routes as a potential treatment for brain disorders. The conclusion from this review is that proper nanoformulations of NRG are a possible therapeutic alternative for the treatment of neurological diseasesKeywords
This publication has 144 references indexed in Scilit:
- PEGylated therapeutics in the clinicBioengineering & Translational Medicine, 2023
- Glioma progression is suppressed by Naringenin and APO2L combination therapy via the activation of apoptosis in vitro and in vivoInvestigational New Drugs, 2020
- Naringenin inhibited migration and invasion of glioblastoma cells through multiple mechanismsEnvironmental Toxicology, 2018
- A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade gliomaCancer Chemotherapy and Pharmacology, 2017
- Nobiletin, a Polymethoxylated Flavone, Inhibits Glioma Cell Growth and Migration via Arresting Cell Cycle and Suppressing MAPK and Akt PathwaysPhytotherapy Research, 2015
- Phase I study of non-pegylated liposomal doxorubicin in children with recurrent/refractory high-grade gliomaCancer Chemotherapy and Pharmacology, 2015
- Simultaneous separation and sensitive detection of naringin and naringenin in nanoparticles by chromatographic method indicating stability and photodegradation kineticsBiomedical Chromatography, 2015
- Naringenin and hesperetin, two flavonoids derived from Citrus aurantium up‐regulate transcription of adiponectinPhytotherapy Research, 2008
- Neurobarrier coupling in the brain: Adjusting glucose entry with demandJournal of Neuroscience Research, 2007
- Glioblastoma cells release factors that disrupt blood-brain barrier featuresActa Neuropathologica, 2004